Publication Cover
Arab Journal of Urology
An International Journal
Volume 22, 2024 - Issue 2
336
Views
0
CrossRef citations to date
0
Altmetric
Stones / Endourology

Mini-PCNL – a boon for CKD patients with nephrolithiasis

ORCID Icon, , , , , , , , , & show all
Pages 115-120 | Received 06 Jul 2023, Accepted 10 Dec 2023, Published online: 26 Dec 2023
 

ABSTRACT

Purpose

The prevalence of urinary stone disease in ESRD is 3.2%, leading to renal damage due to obstructive uropathy, infection, and frequent surgical intervention. PCNL, the gold standard for complex renal stone disease, has evolved with smaller access sheaths (14–20 F), improved optics, and fluoroscopic equipments. This study aims to assess the safety and feasibility of mini- PCNL in CKD patients with respect to postoperative outcome and its effect on stage of CKD.

Patients and methods

This prospective study was conducted in the Department of Urology, Sher-I-Kashmir Institute of Medical Sciences, from January 2022 to October 2022. This study included adult patients with nephrolithiasis at CKD stage 3 or higher. The primary objective of this research was to assess the impact of mini-PCNL on renal function, specifically measuring changes in estimated glomerular filtration rate (eGFR) from baseline to a 6-month follow-up. The secondary objective was to evaluate the feasibility of mini-PCNL in CKD patients in terms of complications, stone clearance rate, and duration of hospital stay. Four variable Modification of Diet in Renal Diseases(MDRD) equation was used to calculate the estimated GFR(eGFR) of each patient and NKF/KDOQI classification system to classify the stage of CKD.

Results

A total of 46 patients were included in the study. We found that for management of nephrolithiasis in CKD patients, mini-PCNL leads to significant improvement in eGFR at 6 months follow-up (mean difference = 14.25 ml/min/1.73 m2; p-value <0.01) with high stone-free rates (89.5%). The complication rates were comparable to standard PCNL.

Conclusions

mini-PCNL is a bonanza for management of CKD patients with nephrolithiasis.

Acknowledgments

I acknowledge this entire work to Department of Urology and Kidney Transplant, Sher-I-Kashmir Institute of Medical Sciences(SKIMS).

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study has not been funded by any individual or organization.